X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (51191) 51191
Book Review (8321) 8321
Publication (3151) 3151
Book / eBook (285) 285
Newsletter (215) 215
Newspaper Article (169) 169
Book Chapter (166) 166
Conference Proceeding (109) 109
Magazine Article (44) 44
Dissertation (33) 33
Data Set (4) 4
Paper (4) 4
Presentation (4) 4
Web Resource (4) 4
Trade Publication Article (2) 2
Transcript (2) 2
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (46870) 46870
humans (43612) 43612
male (23126) 23126
female (21593) 21593
middle aged (16581) 16581
liver neoplasms - drug therapy (16018) 16018
oncology (14750) 14750
animals (14133) 14133
aged (13273) 13273
cancer (12922) 12922
adult (11144) 11144
liver neoplasms - pathology (10177) 10177
liver neoplasms - secondary (9859) 9859
liver cancer (9619) 9619
liver (9079) 9079
hepatocellular carcinoma (8580) 8580
mice (8058) 8058
carcinoma, hepatocellular - drug therapy (7975) 7975
carcinoma, hepatocellular - pathology (7592) 7592
cell line, tumor (6864) 6864
treatment outcome (6823) 6823
chemotherapy (6697) 6697
gastroenterology & hepatology (5962) 5962
metastasis (5940) 5940
tumors (5454) 5454
surgery (5364) 5364
prognosis (5246) 5246
apoptosis (5137) 5137
liver neoplasms - metabolism (5099) 5099
care and treatment (5076) 5076
antineoplastic combined chemotherapy protocols - therapeutic use (5043) 5043
hepatoma (4976) 4976
liver neoplasms - therapy (4958) 4958
antineoplastic agents - therapeutic use (4753) 4753
liver neoplasms - surgery (4500) 4500
expression (4191) 4191
analysis (4149) 4149
carcinoma, hepatocellular - metabolism (4057) 4057
therapy (4040) 4040
hepatocellular-carcinoma (3925) 3925
health aspects (3917) 3917
research (3913) 3913
retrospective studies (3825) 3825
aged, 80 and over (3813) 3813
abridged index medicus (3748) 3748
liver neoplasms - genetics (3650) 3650
pharmacology & pharmacy (3636) 3636
survival (3632) 3632
medicine & public health (3602) 3602
liver neoplasms - mortality (3426) 3426
risk factors (3357) 3357
rats (3355) 3355
colorectal neoplasms - pathology (3351) 3351
carcinoma, hepatocellular - therapy (3248) 3248
antineoplastic agents - pharmacology (3134) 3134
survival rate (3091) 3091
apoptosis - drug effects (3065) 3065
carcinoma, hepatocellular - genetics (2970) 2970
combined modality therapy (2928) 2928
time factors (2915) 2915
colorectal cancer (2849) 2849
antineoplastic agents - administration & dosage (2793) 2793
proteins (2782) 2782
fluorouracil - administration & dosage (2714) 2714
cell proliferation - drug effects (2696) 2696
gene expression (2689) 2689
neoplasm staging (2664) 2664
carcinoma (2611) 2611
mice, nude (2572) 2572
liver - pathology (2527) 2527
medicine (2513) 2513
cancer therapies (2487) 2487
radiology, nuclear medicine & medical imaging (2484) 2484
follow-up studies (2465) 2465
hep g2 cells (2349) 2349
cells (2293) 2293
patients (2293) 2293
development and progression (2258) 2258
research article (2250) 2250
digestive system diseases (2208) 2208
dose-response relationship, drug (2201) 2201
drug therapy (2194) 2194
survival analysis (2186) 2186
biochemistry & molecular biology (2179) 2179
tomography, x-ray computed (2145) 2145
infusions, intra-arterial (2137) 2137
mice, inbred balb c (2136) 2136
cell biology (2123) 2123
carcinoma, hepatocellular - mortality (2122) 2122
liver - drug effects (2091) 2091
liver - metabolism (2053) 2053
liver metastases (2052) 2052
liver neoplasms - diagnosis (2050) 2050
liver diseases (2049) 2049
hepatectomy (2045) 2045
growth (2040) 2040
colorectal neoplasms - drug therapy (1986) 1986
medical prognosis (1986) 1986
article (1982) 1982
liver neoplasms - diagnostic imaging (1982) 1982
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (207) 207
Collection Dvlpm't (Acquisitions) - Closed Orders (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Online Resources - Online (5) 5
St. Michael's Hospital - Stacks (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Humber River Regional Hospital - Church Stacks (3) 3
Scarborough Hospital - General (3) 3
UofT at Mississauga - Stacks (3) 3
Credit Valley Hospital - Reference (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Baycrest Hospital - Stacks (1) 1
Church Stacks (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Humber River Regional Hospital - Pharmacy (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Online (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (46834) 46834
Japanese (2536) 2536
Chinese (627) 627
German (569) 569
French (545) 545
Russian (322) 322
Spanish (173) 173
Italian (156) 156
Hungarian (60) 60
Polish (45) 45
Korean (37) 37
Czech (23) 23
Danish (22) 22
Dutch (19) 19
Ukrainian (15) 15
Swedish (12) 12
Romanian (10) 10
Bulgarian (8) 8
Portuguese (7) 7
Finnish (6) 6
Hebrew (6) 6
Croatian (5) 5
Norwegian (4) 4
Serbian (4) 4
Turkish (4) 4
Arabic (2) 2
Lithuanian (2) 2
Slovak (2) 2
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Pathology, ISSN 0002-9440, 2010, Volume 177, Issue 4, pp. 1647 - 1656
Phosphatase and tensin homolog (PTEN) is a key modulator of trastuzumab sensitivity in HER2-overexpressing breast cancer. Because PTEN opposes the downstream... 
ADJUVANT CHEMOTHERAPY | CELLS | INHIBITION | THERAPY | HUMAN-BREAST-CANCER | MUTATIONS | PATHOLOGY | RECEPTORS | TRASTUZUMAB RESISTANCE | EXPRESSION | CARCINOMA | Lung Neoplasms - drug therapy | Receptors, Estrogen - metabolism | Receptor, ErbB-2 - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Immunoenzyme Techniques | Receptors, Progesterone - metabolism | Young Adult | Carcinoma, Ductal, Breast - drug therapy | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Proto-Oncogene Proteins c-akt - metabolism | Carcinoma, Ductal, Breast - metabolism | PTEN Phosphohydrolase - genetics | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Survival Rate | Lymphatic Metastasis | Brain Neoplasms - drug therapy | Mutation - genetics | Breast Neoplasms - drug therapy | Class I Phosphatidylinositol 3-Kinases | Carcinoma, Lobular - metabolism | Trastuzumab | Bone Neoplasms - mortality | Phosphorylation | Prognosis | Receptor, ErbB-2 - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Liver Neoplasms - mortality | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Brain Neoplasms - secondary | In Situ Hybridization | Lung Neoplasms - secondary | Adult | Female | Bone Neoplasms - drug therapy | Neoplasm Invasiveness | Liver Neoplasms - drug therapy | PTEN Phosphohydrolase - metabolism | Phosphatidylinositol 3-Kinases - genetics | Breast Neoplasms - mortality | Aged | Carcinoma, Lobular - drug therapy | Index Medicus | Abridged Index Medicus | Regular
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2004, Volume 15, Issue 3, pp. 460 - 466
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7693, pp. 538 - 543
Most patients with colorectal cancer die as a result of the disease spreading to other organs. However, no prevalent mutations have been associated with... 
STEM-CELLS | GENE | COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | MOUSE | LEADS | RECEPTOR | MICE | GROWTH-FACTOR | TUMORIGENESIS | EXPRESSION | Intestines - drug effects | Colonic Neoplasms - genetics | Intestinal Mucosa - metabolism | Colonic Neoplasms - drug therapy | Humans | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Stem Cells - metabolism | Th1 Cells - immunology | T-Lymphocytes, Cytotoxic - drug effects | Neoplasm Metastasis - drug therapy | Neoplasm Metastasis - immunology | Colonic Neoplasms - immunology | Immunotherapy | Transforming Growth Factor beta - antagonists & inhibitors | Female | Liver Neoplasms - secondary | Disease Models, Animal | T-Lymphocytes, Cytotoxic - immunology | Transforming Growth Factor beta - immunology | Tumor Microenvironment - drug effects | Th1 Cells - drug effects | Intestines - pathology | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Drug Synergism | Tumor Microenvironment - immunology | Neoplasm Metastasis - genetics | Animals | Cell Differentiation - drug effects | Neoplasm Metastasis - pathology | Colonic Neoplasms - pathology | Alleles | Immune Evasion - drug effects | Stem Cells - drug effects | Stem Cells - pathology | Mice | Mutation | T-Lymphocytes, Cytotoxic - cytology | PD-1 protein | Liver | Colorectal carcinoma | Colorectal cancer | Stem cell transplantation | Cytotoxicity | Lymphocytes T | Metastasis | Metastases | Colon cancer | Intestine | Lymphocytes | Genetic analysis | Fibroblasts | Colon | Inhibition | Growth factors | Phenotypes | Data analysis | Liver diseases | Microsatellites | Organs | Gene expression | Patients | Signaling | Immune checkpoint | PD-L1 protein | Stem cells | Tumors | Cancer | Index Medicus
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 65, Issue 2, pp. 270 - 273
Journal Article
Journal Article
Nature Communications, ISSN 2041-1723, 11/2015, Volume 6, Issue 1, pp. 8760 - 8760
Circulating tumour DNA analysis can be used to track tumour burden and analyse cancer genomes non-invasively but the extent to which it represents metastatic... 
HETEROGENEITY | ACTIVATION | VARIANTS | PATHWAY | MULTIDISCIPLINARY SCIENCES | KINASE | ACQUIRED-RESISTANCE | SEQUENCING DATA | Carcinoma, Ductal, Breast - genetics | Receptors, Estrogen - metabolism | Humans | Receptor, ErbB-2 - metabolism | Clonal Evolution - genetics | Tamoxifen - administration & dosage | Case-Control Studies | Breast Neoplasms - metabolism | Brain Neoplasms - secondary | Carcinoma, Ductal, Breast - drug therapy | Neoplasm Metastasis | Lung Neoplasms - secondary | Adult | Carcinoma, Ductal, Breast - pathology | Female | Quinazolines - administration & dosage | Liver Neoplasms - secondary | Carcinoma, Ductal, Breast - metabolism | Lung Neoplasms - genetics | Liver Neoplasms - genetics | Deoxycytidine - administration & dosage | Brain Neoplasms - genetics | Trastuzumab - administration & dosage | Breast Neoplasms - drug therapy | Sequence Analysis, DNA | Spinal Neoplasms - secondary | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Spinal Neoplasms - genetics | Bayes Theorem | DNA, Neoplasm - genetics | Mutation | Deoxycytidine - analogs & derivatives | Biological evolution | Breast cancer | Genomes | Metastasis | ErbB-2 protein | Patients | Metastases | Heterogeneity | Biopsy | Breast | Evolution | Deoxyribonucleic acid--DNA | Cancer | Tumors | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2015, Volume 33, Issue 34, pp. 4039 - 4047
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2012, Volume 30, Issue 6, pp. 593 - 599
Journal Article